Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholder's Equity (Tables)

Stockholder's Equity (Tables) - Service-Based Vesting Condition Options [Member]

3 Months Ended

Feb. 28, 2018

Stock option activity for the three months ended February 28, 2018, was as follows:


				Weighted		Weighted Average
				Average		Remaining		Aggregate
	Options			Exercise Price		Contractual Life (Years)		Intrinsic Value
Outstanding at November 30, 2017		1,026,979		$	2.50		4.48	$	5,706,107
Granted		—			—				—
Exercised		(1,250	)		1.80				7,963
Expired/forfeited		(6,000	)		2.12				30,240

Outstanding at February 28, 2018		1,019,729		$	2.51		4.38	$	4,744,886

Exercisable at February 28, 2018		999,518		$	2.45		4.32	$	4,707,903

Significant Option Groups Exercisable Option and its Price and Contractual Life

Significant option groups exercisable at February 28, 2018 and related price and contractual life information are as follows:


	Outstanding						Exercisable
			Weighted Average
			Remaining		Weighted Average Exercise Price				Weighted Average Exercise Price
Range of Exercise Prices	Outstanding		Contractual Life (Years)		Weighted Average Exercise Price		Outstanding		Weighted Average Exercise Price
$1.01 to $2.00		422,500		3.69	$	1.73		422,500	$	1.73
$2.01 to $3.00		345,000		2.54	$	2.69		345,000	$	2.69
$3.01 to $4.00		227,229		7.92	$	3.18		218,896	$	3.18
$6.01 to $7.00		25,000		9.09	$	6.95		13,122	$	7.00

		1,019,729		4.38	$	2.51		999,518	$	2.45

Summary of Non-Vested Options

A summary of the status of the Company’s non-vested options as of February 28, 2018, and changes during the three months ended February 28, 2018, is presented below:


				Weighted Average
				Grant-Date
	Options			Fair Value
Non-vested at November 30, 2017		39,168		$	2.41
Granted		—			—
Vested		(18,957	)		2.22
Forfeited		—			—

Non-vested at February 28, 2018		20,211		$	2.59